1 citations
,
January 2004 in “Journal of Clinical Dermatology” Young people with mild hair loss may experience it due to social stress.
March 2026 in “Frontiers in Medicine” A hybrid model using traditional methods, trichoscopy, and AI improves hair loss assessment.
December 2025 in “Actas Dermo-Sifiliográficas” Bicalutamide may improve hair growth in postmenopausal women with mild side effects.
June 2025 in “British Journal of Dermatology” ALUDWIG can help standardize female hair loss assessment from a single image.
January 2025 in “International Journal of Trichology” Severe hair loss may increase the risk of dying from COVID-19.
December 2023 in “Siriraj Medical Journal” 5% Azelaic acid is as effective as 2% Minoxidil for female pattern hair loss and could be an alternative for those allergic to Minoxidil or pregnant.
June 2023 in “Journal of General Procedural Dermatology and Venereology Indonesia” Older, overweight women with children and a family history of hair loss are more likely to experience female pattern hair loss.
April 2023 in “Pakistan Journal of Medical and Health Sciences” Platelet rich plasma treatment is effective for hair loss in both men and women.
January 2018 in “Georg Thieme Verlag eBooks” Hair transplantation is a surgical procedure to move hair to bald areas, requires good donor hair, and results show in about a year.
September 2017 in “Journal of Investigative Dermatology” The combination of Stemoxydine® and Resveratrol improves hair density in women with Female Pattern Hair Loss.
More men have androgenic alopecia than women, with stress linked to the condition in both genders.
January 2009 in “대한피부과학회지” The conclusion is that more women in their forties are getting AGA and stress is linked to AGA in both men and women.
January 2008 in “대한피부과학회지” Androgenetic alopecia is more common in men, often linked to genetics and hormones.
January 2008 in “대한피부과학회지” Androgenetic alopecia is more common in men, linked to genetics and androgen levels, but routine pelvic ultrasound isn't recommended.
January 2003 in “Clínicas pediátricas de Norteamérica” Androgenetic alopecia is a common cause of hair loss, with treatments like minoxidil and hair transplantation available, and new therapies are being developed.
June 2001 in “European Journal of Dermatology” A 54-year-old woman experienced progressive hair loss starting in adolescence, leading to sparse scalp hair and almost no eyebrows or eyelashes.
January 2001 in “대한피부과학회지” Hormone levels in women with androgenetic alopecia are similar to those without the condition.
March 2023 in “Pakistan Journal of Medical and Health Sciences” Low vitamin D levels are linked to higher rates of hair loss in women.
December 2022 in “Pakistan Armed Forces Medical Journal” Androgenetic alopecia may increase the severity of COVID-19.
February 2022 in “Pakistan Journal of Medical and Health Sciences” Taking 2.5mg of finasteride daily can effectively improve hair loss in 62% of women, especially those pre-menopause or with less severe hair loss.
November 2021 in “Journal of The American Academy of Dermatology” Different stages and types of female hair loss are linked with age, menopause, high blood pressure, and skin conditions like acne and hirsutism.
Androgenetic alopecia may be linked to severe COVID-19.
Most severe COVID-19 patients had hair loss, suggesting a possible link.
Vertex accentuation is a common pattern in female hair loss.
January 2016 in “Springer eBooks” The document explains how hair loss in men and women, known as Androgenetic alopecia, is categorized using the Hamilton-Norwood system for men and the Ludwig grade system for women.
January 2007 in “Revista del Centro Dermatológico Pascua” Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.
September 2004 in “PubMed” Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.
September 1998 in “Journal of The European Academy of Dermatology and Venereology” Topical 5α-reductase inhibitor helps counteract hair loss and stabilize it.
666 citations
,
September 1977 in “British Journal of Dermatology” Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.
1 citations
,
January 1996 in “Springer eBooks” Androgenetic alopecia is a condition causing noticeable hair loss, especially in middle age, which is more severe than normal balding.